Status:

UNKNOWN

Intra Bone Marrow Injection Of Unrelated Cord Blood Cells

Lead Sponsor:

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Conditions:

Hematologic Diseases

Eligibility:

All Genders

16-70 years

Phase:

PHASE1

PHASE2

Brief Summary

Compared to other stemcell sources cord blood (CB) is easier and safer to procure, has no donor attrition, a limitless supply, reduced viral transmission, less acute \& chronic GVHD, is rich in hemato...

Detailed Description

Study Design Phase I-II study. Neutrophil recovery \> 80% at day 60 and Platelets recovery \> 80% at days 100 are defined as success. The limit of 60 days for neutrophil recovery was chosen because it...

Eligibility Criteria

Inclusion

  • Patients with hematologic malignancies and other forms of hematologic diseases including aplastic anemia
  • Patients will be eligible to enter the study when: A) an unrelated stem cell transplantation was indicated; b) no suitable unrelated HLA-matched donors will be identified in a clinically useful time-frame.
  • Age 16-70
  • Serum creatinine \<1.5 mg/dL or Creatinine Clearance \>50 ml/min
  • Serum bilirubin \<1.5 mg/dl, SGPT \<3 x upper limit of normal
  • Negative serology for HIV
  • Central Venous access (Central KT) secured through an indwelling catheter.
  • Life expectancy is not severely limited by concomitant illness.
  • Written and signed informed consent

Exclusion

  • Acute Myocardial Infarction (AMI) within the last 12 months
  • Positive pregnancy test
  • Positive HIV serology
  • Chronic renal insufficiency (Serum creatinine \>1.5 mg/dl or creatinine cleareance \<=50 ml/min)
  • Patient has another progressive malignant disease or a history of other malignancies within 2 years prior to study entry.
  • Severe psychiatric illness or any disorder that compromises ability to give truly informed consent for participation in this study.

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2009

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT00696046

Start Date

March 1 2006

End Date

June 1 2009

Last Update

June 12 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

A.O. San Martino - Dep. Center Stem cells and cell therapy"

Genoa, genoa, Italy, 16132

Intra Bone Marrow Injection Of Unrelated Cord Blood Cells | DecenTrialz